Apralogs: Apramycin 5-O-Glycosides and Ethers with Improved Antibacterial Activity and Ribosomal Selectivity and Reduced Susceptibility to the Aminoacyltransferase (3)-IV Resistance Determinant

Citation:
Quirke, J. C. K., P. Rajasekaran, V. A. Sarpe, A. Sonousi, I. Osinnii, M. Gysin, K. Haldimann, Q. - J. Fang, D. Shcherbakov, S. N. Hobbie, et al., "Apralogs: Apramycin 5-O-Glycosides and Ethers with Improved Antibacterial Activity and Ribosomal Selectivity and Reduced Susceptibility to the Aminoacyltransferase (3)-IV Resistance Determinant", Journal of the American Chemical Society, vol. 142, issue 1: American Chemical Society, pp. 530 - 544, 2020.

Abstract:

n/a

Notes:

doi: 10.1021/jacs.9b11601

Related External Link